Atherosclerosis Cardiovascular Disease clinical trials

Explore recruiting atherosclerosis cardiovascular disease clinical trials.

Recruiting atherosclerosis cardiovascular disease studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Atherosclerosis Cardiovascular Disease trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

J2A-MC-GZPW: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Event-Driven Study to Investigate the Effect of Orforglipron on the Incidence of Major Adverse Cardiovascular Events in Participants With Established Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease

Germany, Czechia, Lithuania, Spain, Austria, France +10 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Atherosclerosis Cardiovascular Disease trials by city

Atherosclerosis Cardiovascular Disease clinical trials

Recruiting atherosclerosis cardiovascular disease studies right now

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Predictive Value of Systolic Rise Time of the Plantar Arch on the Risk of Major Adverse Limb Events (MALE) and Major Adverse Cardiovascular Events (MACE) in Peripheral Artery Disease (PAD) at Critical Ischaemia Stage

Penn Medicine Healthy Heart

Impact of Treating Severe Periodontitis on Inflammatory Activity of Atheromatous Plaques in Patients With Acute Myocardial Infarction (AMI)

Evaluating the Safety and Efficacy of the G-stream® Drug-Eluting Stent in the Above-the-Knee Femoropopliteal Artery

Serrantor OCT Study

Carnosine for Peripheral Arterial Disease Patients

Red Light Treatment in Peripheral Artery Disease

SGLT2 Inhibitors on Coronary Atherosclerosis Progression Via Perivascular Adipose Tissue in Diabetes

The Effects of Diet and Exercise Interventions in Peripheral Artery Disease

Coated or Chewable Aspirin and a Hybrid Strategy to Mitigate Adverse Effects of Air Pollution in Stable Atherosclerotic Disease

Leg Exercise Assistive Paddling (LEAP) Therapy for Peripheral Artery Disease

Also recruiting in Europe

J2A-MC-GZPW: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Event-Driven Study to Investigate the Effect of Orforglipron on the Incidence of Major Adverse Cardiovascular Events in Participants With Established Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease

Atherosclerosis Cardiovascular Disease trials by city

Other conditions